Groves Samantha J, Douglas Katie M, Porter Richard J
Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.
Specialist Mental Health Services, Canterbury District Health Board, Christchurch, New Zealand.
Front Psychiatry. 2018 Aug 28;9:382. doi: 10.3389/fpsyt.2018.00382. eCollection 2018.
Research suggests that only 50% of patients with major depression respond to psychotherapy or pharmacological treatment, and relapse is common. Therefore, there is interest in elucidating factors that help predict clinical response. Cognitive impairment is a key feature of depression, which often persists beyond remission; thus, the aim of this systematic review was to determine whether baseline cognitive functioning can predict treatment outcomes in individuals with depression. Studies examining cognitive predictors of treatment response in depression were identified using Pub Med and Web of Science databases. Given the heterogeneity of outcome measures, the variety of treatment protocols, and the differing ways in which data was presented and analyzed, a narrative rather than meta-analytic review technique was used. 39 studies met inclusion criteria. Findings in younger adult samples were inconclusive. There was some evidence for a predictive effect of executive function and to a lesser extent, psychomotor speed, on treatment response. There was no evidence of learning or memory being associated with treatment response. In older-aged samples, the evidence was much more consistent, suggesting that poor executive function predicts poor response to SSRIs. Findings from the present review suggest that certain aspects of cognitive functioning, particularly executive function, may be useful in predicting treatment response in depression. This is certainly the case in elderly samples, with evidence suggesting that poor executive functioning predicts poor response to SSRIs. With further research, baseline cognitive functioning may serve as a factor which helps guide clinical decision making. Moreover, cognitive deficits may become targets for specific pharmacological or psychological treatments, with the hope of improving overall outcome.
研究表明,仅有50%的重度抑郁症患者对心理治疗或药物治疗有反应,且复发很常见。因此,人们对阐明有助于预测临床反应的因素很感兴趣。认知障碍是抑郁症的一个关键特征,往往在缓解后仍持续存在;因此,本系统评价的目的是确定基线认知功能是否能预测抑郁症患者的治疗结果。通过PubMed和Web of Science数据库检索了研究抑郁症治疗反应认知预测因素的研究。鉴于结果测量的异质性、治疗方案的多样性以及数据呈现和分析的不同方式,采用了叙述性而非Meta分析的综述技术。39项研究符合纳入标准。在年轻成人样本中的研究结果尚无定论。有一些证据表明执行功能对治疗反应有预测作用,心理运动速度的预测作用较小。没有证据表明学习或记忆与治疗反应有关。在老年样本中,证据更为一致,表明执行功能差预示着对选择性5-羟色胺再摄取抑制剂(SSRI)反应不佳。本综述的结果表明,认知功能的某些方面,特别是执行功能,可能有助于预测抑郁症的治疗反应。在老年样本中确实如此,有证据表明执行功能差预示着对SSRI反应不佳。随着进一步研究,基线认知功能可能成为有助于指导临床决策的一个因素。此外,认知缺陷可能成为特定药物或心理治疗的靶点,以期改善总体治疗效果。